Clearside Biomedical exits Chapter 11 with Steel Partners backing
Clearside Biomedical, Inc. completed its financial restructuring and emerged from Chapter 11, sponsored by Steel Partners, Ltd. An affiliate of Steel Partners acquired 80% of the total voting power and provided a $3 million senior secured revolving credit facility. The reorganized company retains intellectual property and is free of legacy liabilities.
*this image is generated using AI for illustrative purposes only.
Clearside Biomedical, Inc. has completed its financial restructuring and emerged from Chapter 11, sponsored by Steel Partners, Ltd. The reorganized company now operates with a recapitalized balance sheet free of legacy liabilities, retaining intellectual property including patents, trademarks, and domain names. Steel Partners provided new equity capital and credit support to facilitate the emergence, which was confirmed by the United States Bankruptcy Court for the District of Delaware. Clearside had commenced its Chapter 11 case on November 23, 2025.
Under the plan of reorganization, an affiliate of Steel Partners purchased newly issued common shares representing approximately 30% of the company’s aggregate economic interest and 80% of its total voting power on an as-converted, fully diluted basis. Holders of the company’s existing common stock retained approximately 70% of the economic interest, subject to dilution and customary reorganization adjustments. Additionally, Steel Partners provided a $3 million senior secured revolving credit facility for working capital and general corporate purposes.
Ownership Structure and Capital
The transaction structure allocates voting power and economic interest between the sponsor and existing shareholders. The proceeds from the transaction were reserved to satisfy allowed claims.
| Stakeholder | Economic Interest | Voting Power |
|---|---|---|
| Steel Partners Affiliate | Approximately 30% | Approximately 80% |
| Existing Common Stockholders | Approximately 70% | Remainder |
Intellectual Property and Tax Attributes
A central objective of the transaction is the rehabilitation or use of the retained intellectual property, which the company intends to develop or monetize over time with Steel Partners’ support. As of December 31, 2025, the company held federal net operating loss (NOL) carryforwards of approximately $290.5 million. After projected 2026 utilization and anticipated attribute reduction resulting from bankruptcy emergence, the company expects approximately $275.9 million of federal NOL carryforwards to remain available, subject to final determination.
The company has recorded a valuation allowance against substantially all of its net deferred tax assets as of December 31, 2025, as management determined it is more likely than not that the deferred tax assets will not be realized. The certificate of incorporation includes a provision intended to preserve tax benefits, prohibiting transfers of stock that would result in a person or group becoming a 4.90 percent stockholder or altering existing holdings at that threshold.
What specific strategies will Clearside employ to monetize its retained intellectual property under Steel Partners' guidance?
How will the company utilize the $3 million revolving credit facility to drive operational growth in the coming year?
What milestones must Clearside achieve to release the valuation allowance against its net deferred tax assets?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
